27 results
8-K
EX-99.2
bsfnq6
17 Oct 22
Results support potential clinically meaningful activity of fosgonimeton without background therapy and mitigate program risk
8:30am
8-K
EX-99.2
ffdiuudmgbep
22 Jun 22
Athira Pharma Announces Topline Results from ACT-AD Phase 2 Proof of Concept Study of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease
7:05am
DEFA14A
yd862s9v2gr3gol4p5
11 Apr 22
Additional proxy soliciting materials
4:36pm
10-K
povfyg
25 Mar 21
Annual report
12:00am
424B4
gyjq xmft9538
21 Jan 21
Prospectus supplement with pricing info
12:00am
8-K
EX-99.1
u80pjba3vbhwzgvdn61e
11 Jan 21
Departure of Directors or Certain Officers
6:03am